SCHEMBL7155286

SCHEMBL7155286

CC(C)(C)[Si](OC[C@@H](O)CC[C@H](O)CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.37
RIPK1 Q13546 1/20 0.36
CYP3A4 P08684 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
SMYD2 Q9NRG4 2/20 0.34
LMNA P02545 2/20 0.34
CYP1A2 P05177 2/20 0.33
KDM4E B2RXH2 1/20 0.33
AGTR1 P30556 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CA1 P00915 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24312400 0.95 CYP2D6 (0.38) CYP2D6CYP3A4HTTSMN1; SMN2KMT2A
SCHEMBL30335638 0.94 CYP2D6 (0.34) CYP2D6RIPK1CYP3A4HTTSMN1; SMN2
SCHEMBL3834273 0.92 SLC6A2 (0.36) CYP2D6RIPK1CYP3A4HTTSMN1; SMN2
SCHEMBL21873649 0.92 CYP1A2 (0.42) CYP2D6CYP3A4HTTSMN1; SMN2KMT2A
SCHEMBL218117 0.92 CYP1A2 (0.42) CYP2D6CYP3A4HTTSMN1; SMN2KMT2A
SCHEMBL2531862 0.92 CYP1A2 (0.42) CYP2D6CYP3A4HTTSMN1; SMN2KMT2A
SCHEMBL28885790 0.91 TRPA1 (0.36) CYP2D6RIPK1CYP3A4HTTSMN1; SMN2
SCHEMBL28885789 0.91 TRPA1 (0.36) CYP2D6RIPK1CYP3A4HTTSMN1; SMN2
SCHEMBL6158503 0.90 CYP3A4 (0.37) CYP2D6CYP3A4HTTSMN1; SMN2KMT2A
SCHEMBL9523633 0.90 GAA (0.36) CYP2D6CYP3A4HTTSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6632953-B1 Metal complex comprising a phospholane as claimed in any of claim 1 and a central atom selected from the group of Rh, Ru, Ir, Pd, Pt, Ni. asymmetric hydrogenation of compounds by reacting the starting compounds to be hydrogenated with BASF AKTIENGESELLSCHAFT (DE) 2003-10-14 US disclosed
EP-0992481-B1 Process for the asymmetric hydrogenation of beta-ketoesters BASF AG (DE) 2003-05-21 EP disclosed
EP-1082328-B1 PRODUCTION OF OPTICALLY ACTIVE PHOSPHOLANES BASF AG (DE) 2002-11-20 EP disclosed
EP-0992481-A1 Process for the asymmetric hydrogenation of beta-ketoesters BASF AKTIENGESELLSCHAFT (DE) 2000-04-12 EP disclosed